Lila Bio raises $3.65M
Lila Bio announced a Debt/Non-dilutive round of $3.65M on 11 November 2026. The company operates in HealthTech and is based in United States. It was founded by Jake Kraft, CEO & Co-founder. Announced 2 days ago.
Founder
Jake Kraft
CEO & Co-founder, Lila Bio
Outreach angles
- -Jake Kraft was a postdoctoral fellow at the University of Washington's Institute for Protein Design, directed by Nobel laureate David Baker.
- -Kraft co-founded Lila Bio with chief scientist Anindya Roy in 2023, raising $10M in seed funding that year.
- -Lila Bio won a $3.65M NIH fast-track grant to develop an injectable protein treatment for pulmonary hypertension.
Signals
DebtDeep TechHealthcareAI-Native
Round details
Company: Lila Bio
Domain: lila.bio
Amount: $3.65M
Stage: Debt/Non-dilutive
Industry: HealthTech
Country: United States
Announced: 11 November 2026
Other HealthTech raises
Recently funded in United States